GLP1R and type 1 diabetes mellitus: A meta-analysis of GLP-1 RAs as adjuvant therapy in patients with T1DM also observed that liraglutide was associated with higher odds of ketosis (OR 1.8; 95% CI, 1.1–2.8) (Park et al., 2023).